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Abstract
Background: The adult medicinal leech central nervous system (CNS) is capable of regenerating specific synaptic circuitry
after a mechanical lesion, displaying evidence of anatomical repair within a few days and functional recovery within a few
weeks. In the present work, spatiotemporal changes in molecular distributions during this phenomenon are explored.
Moreover, the hypothesis that neural regeneration involves some molecular factors initially employed during embryonic
neural development is tested.
Results: Imaging mass spectrometry coupled to peptidomic and lipidomic methodologies allowed the selection of
molecules whose spatiotemporal pattern of expression was of potential interest. The identification of peptides was aided by
comparing MS/MS spectra obtained for the peptidome extracted from embryonic and adult tissues to leech transcriptome
and genome databases. Through the parallel use of a classical lipidomic approach and secondary ion mass spectrometry,
specific lipids, including cannabinoids, gangliosides and several other types, were detected in adult ganglia following
mechanical damage to connected nerves. These observations motivated a search for possible effects of cannabinoids on
neurite outgrowth. Exposing nervous tissues to Transient Receptor Potential Vanilloid (TRPV) receptor agonists resulted in
enhanced neurite outgrowth from a cut nerve, while exposure to antagonists blocked such outgrowth.
Conclusion: The experiments on the regenerating adult leech CNS reported here provide direct evidence of increased titers
of proteins that are thought to play important roles in early stages of neural development. Our data further suggest that
endocannabinoids also play key roles in CNS regeneration, mediated through the activation of leech TRPVs, as a thorough
search of leech genome databases failed to reveal any leech orthologs of the mammalian cannabinoid receptors but
revealed putative TRPVs. In sum, our observations identify a number of lipids and proteins that may contribute to different
aspects of the complex phenomenon of leech nerve regeneration, establishing an important base for future functional
assays.
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Introduction
A notable property of medicinal leech central neurons is their
capacity to regenerate neurites and restore appropriate synaptic
connections in the adult central nervous system (CNS): neurites
that have been damaged or severed can sprout, establish de novo
growth cones, extend long distances and reconnect specifically
with normal targets [1]. In some instances, this process is greatly
facilitated by the fusion of the proximal and distal regions of a cut
axon [2]. A possible explanation for this useful attribute is that
there is, in the adult leech, a continued presence and capacity for
up-regulation of embryonic factors employed in early neuronal
growth and maturation. Leech central neurons continue to expand
their central and peripheral arbors throughout most of the life of
the animal (animals get bigger following individual feedings),
suggesting the possibility that the machinery for growth and
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completely in this invertebrate group. Alternatively, medicinal
leeches may possess an unusual ability to enhance expression or
repression of critical factors in response to signals produced
internally by the damaged neuron or released extracellularly by
the damaged tissues. These ideas can be tested by the detailed
molecular analysis of changes in gene expression provoked by
physical damage to the CNS, which is the subject of this report.
Over the past decade, Blackshaw and collaborators have
implemented a differential screening strategy in order to assay
directly for changes in gene expression at the transcriptional level
that accompany neuronal regeneration in the leech [3–6]. Their
approach is based on the use of subtractive probes, constructed by
hybridizing cDNAs from regenerating and non-regenerating
central ganglia and selecting these sequences enriched either in
the regenerating sample (up-regulated genes) or in the non-
regenerating sample (down-regulated genes). These probes were
then used to screen cDNA libraries constructed from whole leech
CNS or from identified micro dissected neurons [3,6]. Thus far,
this procedure has yielded a number of interesting results. For
example, among sequences found to be up-regulated 24 hours
following axotomy are the leech homologues of mammalian genes
with established functions, such as genes encoding the cytoskeletal
proteins actin, tubulin and Protein 4.1; thioredoxin (TRX), Rough
Endoplasmic Reticulum Protein 1 (RER-1) and ATP synthase;
and the neuron-specific protein synapsin. Others, such as the
Cysteine Rich Intestinal Protein (CRIP), have been previously
shown to be expressed in developing mammalian intestinal cells
but not in adult regenerating nerve cells [3]. Other genes regulated
by injury in the leech have counterparts in the mammalian
genome but are not known to participate in mammalian
regeneration processes. Two identified regulated genes, myohe-
merythrin [7] and the novel protein ReN3, are exclusively
expressed in invertebrates. Still other regulated genes have no
known homologues in vertebrate genomes, and these invertebrate-
specific sequences are interesting in view of the different capacity
for CNS repair in invertebrates such as the leech [3]. In order to
investigate the key role of such genes in regeneration, siRNA
studies have to be undertaken. RNAi studies at the single cell level
have demonstrated the feasibility of such studies in leeches [8].
While these studies are at an early stage, it is quite clear that
further analyses, particularly those examining the time course of
injury-evoked changes in gene expression, have the potential to
yield useful information, at a systems level, on the genetic
programs underlying nervous system repair.
Studies of the modulation of gene expression at the mRNA level
are clearly important, but they need to be complemented by
observations of changes in protein levels and protein modifications
using proteomics tools, as some of the critical effects of injury may
be manifested in the regulation of translation and post-transla-
tional processing. Interestingly, several molecules detected in the
differential transcription studies mentioned above have also been
identified in recent proteomic studies of excised leech CNS
challenged with bacterial toxins. These include cytoskeletal and
metabolic proteins, foldases, calcium sensors, kinases and neuro-
hemerythrin [9]. While this is a comparison of two levels of
analysis - transcriptomic and proteomic - and responses to two
different types of stress - mechanical trauma and septic shock - it is
nonetheless satisfying that there is a convergence of results. An
additional level of analysis needs to be considered, however. Lipids
may also be critically involved in aspects of regeneration and
repair, and these must be explored using lipidomic techniques.
In the work reported here, lipidomic and peptidomic assays
coupled to molecular mass spectrometry imaging were used to
explore molecular changes, by location and as a function of time
after injury, that occurred in response to mechanical trauma and
isolation of the leech CNS. A parallel embryonic study assessed
whether molecules thus identified were also detected during
development. The collected data provide an initial basis for the
further exploration of a mechanistic understanding of the
physiological processes involved in neural regeneration, including
regulation of nitric oxide (NO) production, modulation of the
innate immune response, the expression of neurotrophic and
neurogenic factors, in the leech and other animals.
Results
Modulation of protein and peptide distributions during
neural regeneration
Distributions of peptides/proteins in lesioned ganglion
highlighted by MALDI imaging mass spectrometry. In
order to obtain a global map of peptides/proteins that might be
involved in leech adult CNS regeneration at the ganglionic level,
we performed MALDI mass spectrometry imaging (MSI) of
sections of regenerating adult CNS following mechanical damage.
Adult experimental animals received a crush in the connective
nerves near the anterior margin of midbody ganglion 9, leaving
the rest of the nerves between ganglia intact (Figure 1A). After
allowing 6 hours for regeneration to be established, frozen 10 mm
cross sections of whole animals were cut from anterior of the crush
site to posterior of ganglion 9. Nine sections covering ganglion 9
from anterior (section 1) to posterior (section 9) were then imaged
with MALDI-TOF in the region of the nervous system
(Figure 1C, panel (2)). The spectra were taken in the range of
m/z from 1,000 to 30,000 Da and normalized. To facilitate the
comparison and interpretation of the data, the spectra for all
sections were plotted together in a two-dimensional
representation, with the spectra displayed as parallel horizontal
lines, m/z values along the abcissa and intensity at each point
represented by color (blue=low, white=high; scale on the left),
and the set of spectra for each section separated from each other
by thick lines (Figure 1B). The spectra obtained for all 9 cross-
sections of the ganglion were then subjected to principal
component analysis (PCA) followed by hierarchical clustering.
The dendrogram of the clustering results shows that spectra
represented by some branches of the dendrogram correspond to
more anterior locations while others appear to be more posterior
and are more numerous (Figure 1C and Figure S4). These
statistical analyses highlight two distinct areas, corresponding to
the anterior (red, orange) and the posterior (blue) parts of the
ganglion, and show significant differences in terms of their nature
and level expression. This suggests that peptides are produced by
neurons that reside closer to the lesion or that factors are
differentially transported towards the damaged area. For example,
the peptide with the m/z of 2475, previously detected in the
embryo nerve cord (Figure 2A) is also present in the adult
regenerating ganglion with an anterior expression bias
(Figure 2B), whereas it is absent in controls (non regenerating
adult CNS segmental ganglia, Figure S1). This peptide, which
has been recently identified as a fragment of a novel intermediate
filament protein, HmIF4 [10] and has the N-terminal sequence
GTRTMERSVRTSSQYASGGPMPN, provides evidence for the
idea that embryonic factors are re-expressed or up-regulated
during the process of regeneration.
Since the leech nerve cord resides within the ventral blood sinus,
it is important to assay whether factors produced at the lesion site
might be derived from blood cells instead of the CNS tissues
proper. In this context, MSI was performed on the sections of an
Regenerating CNS of the Medicinal Leech and MSI
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tissue of ganglion 9 and the surrounding area of the blood sinus.
PCA followed by hierarchical clustering yield a dendrogram with
two major branching domains (red and green branches;
Figure 3A). When these are related to the corresponding tissue
locations, one set of branches (green) clearly corresponds to
ganglionic cells while the other (red) is present in the cells within
the surrounding blood sinus (Figure 3B). The distributions of
these two proteic profiles in some of the sections (sections 5 and 6,
Figure 3B) suggest that cells contained within the sinus also
participate in the regeneration process by migrating into the
ganglion. Observation of two distinct profiles, specifically high-
lighted in the blood sinus or in the ganglion in control sections of
adult leech, seems to confirm this hypothesis (Figure S2). These
observations support the concept that several classes of cells
participate in the regeneration processes including neurons,
microglia and blood cells. In the course of regeneration,
communication among these cells might involve different classes
of molecules at each step of this biological process. We previously
demonstrated that, early in the process, regenerating neurons
produce chemoattractive factors related to chemokines, e.g.,
HmEMAPII [11], HmIL16 [12] and HmC1q [13], which are
present in both leech and human microglia [11–13] and
antimicrobial-neurotrophic factors, e.g., neuromacin and Hm-
lumbricin [14]. Finally we recently characterized these blood cells
as hemocytes able to produce neurotrophic factors related to the
Figure 1. MALDI-MSI analysis of peptides in sections of regenerating adult CNS. A. Image of the dorsal aspect of a live adult specimen of a
medicinal leech (Hirudo verbana), head up (left part). Drawing features the ventral nerve cord, from the head ganglion to the tail ganglion, including
the 21 midbody ganglia (right part). The location of the connective nerve crush, anterior to midbody ganglion 9 (red scissors), and the nine cross-
sections (panel C2) are indicated. Example of a live midbody ganglion in culture (insert on the right). The interganglionic connective nerves and the
nerve roots are labeled [19]. B. Two-dimensional representation of all the mass spectra (range m/z =1,000 to 30,000) corresponding to locations
within a ganglion in the 9 sections (panel C2) shows variations in protein expression. The spectra are displayed as adjacent parallel lines in bands
corresponding to each section (right of the graph). The number of pixels varies among sections, leading to bands of different widths. The spectra are
normalized and ionic signal intensity is coded according to the color scale bar (0%: black to 100%: white) (left of the graph). (Section distribution for
individual m/z values is diagrammed in Figure S4). C.( 1) Full dendrogram shows the results of hierarchical clustering following principal component
analysis of the MALDI-MSI dataset from 9 sections of the regenerating adult ganglion (panel B). The numbers in brackets correspond to the number
of spectra per branch, and the horizontal numbers to the branch distances. (2) Reconstruction of selected dendrogram branches and corresponding
images superposed on the 9 tissue sections, with each pixel color coded according to dendrogram branch. Only those pixels in the area of the
ganglion are shown, superposed on the tissue image. Top row, sections 1-3, middle row, sections 4-6, bottom row, sections 7-9. Note that the
number of pixels varies among sections.
doi:10.1371/journal.pone.0018359.g001
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omyzin and Hm-theromacin [16]. The sum of these observations
argues for a critical role of blood cells in neuronal regeneration.
Peptide/protein identification. Two strategies were
employed to assay changes in the expression of peptides and
proteins resulting from mechanical damage to the CNS: a global
approach, using a ‘‘bottom-up’’ application to observe the adult
CNS in the course of regeneration but focused on the peptides or
proteins identified specifically during neurogenesis, and a targeted
approach, based on Differential-Display HPLC (DD-HPLC),
neurite outgrowth and antimicrobial tests. The main goal of
these two strategies was to identify candidate peptides/proteins
which are likely to have important functions in the process of adult
CNS regeneration.
The Bottom-up strategy was based on the hypothesis that many
factors that are important and useful in the reconstruction of the
nervous system after injury ought to also be present during the
initial ‘‘construction’’ phase, i.e., during neural differentiation.
Thus, the criteria for selecting specific peptides or protein
fragments for further analysis in this set of experiments was
detectability during neurogenesis as well as during regeneration.
For this purpose, we extracted peptides from stage E12 embryos (a
midstage in neurogenesis) and from adult nerve cords 6h after
lesioning the connective nerves in vivo. Following acidic extraction
and sep-pack prepurification, the 50% AcN fractions were
subjected to trypsin digestion before being separated in nanoLC
and characterized in ion-trap using MS/MS mode, and analyzed
using InsPecT software [17] against predicted translated sequences
in the Hirudo medicinalis EST database [18] and Helobdella robusta
genome (http://genome.jgi-psf.org/Helro1/Helro1.home.html).
Each identified peptide sequence was then blasted using NCBI
p-Blast against Hirudinidae species. Table 1 presents a sample of
the identified proteins present in both adult nerve cords in
regeneration (absent in control) and leech embryos (sequence
alignment Figure S3) based on identified trypsin sequenced
peptides after nanoLC separation. These can be grouped into six
different functional categories: antimicrobial-neurotrophic factors,
chemoattactractant factors, axonal guidance factors, gap junction-
al proteins, homeobox gene factors, and Ig superfamily proteins,
representing the broad functional requirements of these dynamic
processes.
Differential Display (DD)-HPLC analyses coupled to neurite
outgrowth and antibacterial assays were performed on peptidic
extracts of nerve cords maintained in culture for different times
post axotomy (Figure 4). Comparison of the HPLC spectra
revealed six peaks in the range considered that changed
significantly in the course of the experiment, from T0 to 1 week
post axotomy. The identification of the peptides contained in these
fractions was performed by combining further HPLC purification,
mass spectrometry analysis and Edman degradation. The m/z
values, amino acid sequences and proposed identities are
presented in Table 2. The first peak (Peak 1; Figure 4), which
Figure 2. Expression of the ion at m/z 2475 in both embryonic and regenerating adult CNS segmental ganglia. A. Distribution of the m/
z 2475 ion in a 12-day old leech embryo determined by MALDI-MSI of a dorsally-opened, whole mounted specimen. The ion is found at the highest
abundance in the segmental ganglia of the ventral nerve cord. Head on the left, tail on the right, dorsal midline on the upper and lower margins of
the dissected embryo. B. Distribution of the m/z 2475 ion in sections of the regenerating adult ganglion analyzed in Figure 1. The insert shows a
magnified image of the data for section 4, with the abundance of the ion color coded according to the color bar at right. The peak corresponding to
this ion is absent in a control adult (Figure S1), indicating a strong up-regulation of expression following injury.
doi:10.1371/journal.pone.0018359.g002
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neurotrophic activity in leech neurite outgrowth tests (Figure 4,
left upper insert). It represents a value m/z 3974 and has the
following N-terminal sequence, obtained by Edman degradation:
RRLPKFPKFPKFPKLPDWPQWPEWPQE, Querying the Hi-
rudo Genome, the complete sequence is the following:RRL
PKFPKFPKFPKLPDWPQWPEWPQEQQLQEWPPEEGLSE.
This is a novel peptide and shows antibacterial activity in our
assay (see Methods) which we have named Hm-ABP3. Two other
peaks selected for further analysis also turned out to be
antimicrobial peptides (AMPs), but two that we had previously
identified in the leech CNS, Hm-lumbricin (Peak 2, Figure 4)
and Hm-neuromacin (Peak 3, Figure 4)[ 1 4 ] .B o t ho ft h e m
display antimicrobial activity (upper right insert, Figure 4), and
both show neurotrophic properties in neurite outgrowth tests as
we have previously shown [14]. The remaining three peaks also
correspond to previously identified leech proteins. Peak 4
(Figure 4) represents a peptide sequence related to the
intermediate filament gliarin [9], while Peaks 5 and 6 are both
related to neurohemerythrin [7]. Neither antimicrobial nor
neurotrophic activities were detected for any of these three
molecules (data not shown).
In contrast to the kinetics of Hm-ABP3, the levels of Hm-
lumbricin and Hm-neuromacin decreased a week post axotomy,
after increasing for at least 3 days. This observation, in addition to
their constitutive expression in the nerve cord, suggests that these
two AMPs are mainly involved in the early events of neural repair.
Similar to Hm-ABP3, the gliarin fragment and the neurohemer-
ythrin isoforms appeared to become more abundant throughout
the period examined, suggesting that their roles might become
more important as the process of regeneration is established, but
might not be as significant immediately after the lesion is made,
when the neuroinflammatory response occurs [11–14,19,20].
Curiously, the two neurohemerytrin isoforms are differentially
Figure 3. Hierarchical clustering of spectra from 9 sections of a regenerating ganglion and surrounding blood sinus. A. Drawing of
the leech structure features the ventral blood sinus surrounding the nerve cord [89]. B. Full dendrogram of all spectra in the ganglion dataset yields
two main branches, colored red and green, that segregate into different domains in the images (panel C). C. Reconstruction of selected dendrogram
branches and corresponding images shows that the upper branch (red) corresponds mainly with the blood cells (annulus around the central region)
while the lower branch (green) corresponds mainly to cells in the CNS region. In some sections, however, cells characterized by the blood sinus
peptide profile (red) appear to have migrated into the area of the ganglion (sections 5 and 6 in particular).
doi:10.1371/journal.pone.0018359.g003
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results are consistent with the data obtained by the bottom-up
approach, supporting the tentative conclusion that gliarin and
antimicrobial-neurotrophic factors are implicated in the adult
nerve cord regeneration. In addition, our observations comple-
ment those obtained by genomic and 2D-Gel proteomic studies
[3,5,7,9] (Table 3). By comparison, Blackshaw and collaborators
have reported, in studies using subtractive cDNAs library from
regenerating and non-regenerating central ganglia, the presence of
leech homologues of mammalian genes with established functions,
including the cytoskeletal proteins actin, tubulin and Protein 4.1,
ATP synthase, the neuron-specific protein synapsin, Cysteine Rich
Intestinal Protein (CRIP), myohemerythrin and a novel protein
ReN3, exclusively expressed in invertebrates [3,4,21,22]. To
investigate the possible roles of such genes in regeneration, siRNA
studies have to be undertaken [6]. Similarly on-going proteomic
studies of the leech CNS performed by our group have shown that
some molecules detected by transcriptomic approaches, e.g.
cytoskeletal and metabolic proteins, foldases, calcium sensors,
kinases and neurohemerythrin (reflecting specific cytoskeletal
rearrangements linked to cell migration), vesicular trafficking as
well as the modulation of synaptic activity, are also observed in
excised adult ganglia challenged by bacterial toxins [7,9].
Time course changes of proteome of lesioned
ganglion. Based on previous proteomic [7,9] and genomic
studies [3,21] and peptides quantifications obtained by DD-HPLC
or from the identification of peptides in trypsin digests by MS/MS
after nanoLC separation (see Methods), it is possible to propose a
possible scheme for how the factors implicated in the regeneration
processes might be involved from lesioning (time 0) to day 7. As
presented in Table 4, immune factors implicated in
neuroinflammation, such as antimicrobial peptides and
chemoattractants, are released early (between 1 h to 6 h) in
order to activate microglial cells and initiate the regeneration
process. Inflammation is necessary in order to start the wound
healing at the periphery. In the brain, neuroinflammation is also
necessary for activating specific cells and for the release of
regeneration messengers. Thus, the detection of EMPAII [11],
IL16 [12], C1q [13,20] and the antimicrobial peptides [14] is
expected. The second wave of molecules seems to be related to
physical reconstruction and tissue repairing, with the up-regulation
of cytoskeleton proteins and modulatory components like
myohemerytin, filarin, gliarin, macrolin, leech CAM, and tractin
[7,23–27]. All of these proteins support the neuronal outgrowth
that will be responsible for reconnecting neurons. Then neuronal
sprouting and axon guidances proteins, like liprin, hillarin, leech
Ena, netrin and syntaxin [23,28–30] can be detected. This is then
followed by a phase in which, during the course of tissue repair,
signaling pathways are reestablished through the heightened
expression of novel hemi-channels related to gap junctions
formation (innexins), synapsin, ReN3, voltage-gated Na channels
isoform [3,21,31,32].
Changes in lipid expression following mechanical trauma
Beside lipids are also known to be involved in inflammation
modulation and brain regeneration [33]. As expected, screening of
the leech EST database revealed the presence of partial transcripts
for many enzymes involved in lipid metabolism, including
phospholipase A2 (cytosolic and calcium-independent forms),
phospholipases D3 and C, lysophospholipase, and arachidonate
15-lipoxygenase type II (Table 5). The presence in the leech
nervous system of some of the major lipid enzymes implicated in
Table 1. Proteins detected in both regenerating adult nerve cord and in embryos.
Identified Proteins Identified Sequences
Destabilase I LIAQLKVNSQFTDSCLR
Neuromacin GLFMYMIGFLLLSDCNSNWATTRLDKSSLIGILWKNCNER
C1q domain DRIFSSGSSGEDDDDDDDDDSKNSNYLLTKLGPRGTAGPDGVVGQKGDSGELGPPGLPVTTSTRNMLEGDDR
Interleukin 16 related Protein RSEPRQNMHLRRKD.FTKPRKNCLASMTS.RS.SFFAGALGVTFCVEGGR
P43/EMAPII FIDIQGFLCPLRWTGGFAVSKTQLLGGTPRHSKALQFCRE.AVDGVQIRPPAGVSVPGRGAADPR
AVVAGGLSLCPQGADQGRNPSSKQQSSAVCSTVVCK
Filamin ESGSGIPTTATEAVDGVQIRKMRSKSVPSTGESFTSTSTGTPGMETFTSSAPKMGDQGGITKNTPCTGSFT
RWTGGFAVSKTQLLGGTPRHSKALQFCRSADRECPDFLTTKAFGTSPESGSGIPTTATKEAVDGVQ
IRPPAGVSVPGRGAADPRAVVAGGLSLCPQGADQGRQGEDAGKFAATEIKVTAVDASSGQHVDSSIDKF
SEFATQISIQTIPFIASLLLLCTMAGDLALVIRLSVSCSKRSLPGLGSGSSPLVGRGNGRGGRNPSSKQQSSAVCSTVVCKPDLDAISGELVK
Hillarin A.SLLICNMNSLLSDCSLLERNLVGDKGRNLKI.LAFFLFQKIFKP.ASEALACSSSSLVIAMTLPGKKLSSG
RSSRASCSSSSNSAKRSSSSTSPNPTGFEIAFEISKI.LAFFLFQKIFKYNLQIILL.YR
Macrolin VHQEQNLMLISKNSNYLLTKGAVAAAVCTLNSGFLVAEENTRDDGLGHLGVHGRIVGRIDGTGAECGRIG
NSLRPASIHSSDLEARSWGLNQRLVTGLISYSADLKDGQVTTSTRNMLEGDDRGTTEYPFK
Tractin SLRVEDVIKEGNNPLQQIHRCGKGLPLLIFLPGGGPTLPTKNFKIRDLLVSSSATSVVGWPE
IRF.LLLIATDDSLQLESLHDAPNKLNNNYKNIQKA.ASVSSLASKKNIFVNTFHVKG.NRHSPGQEVQ
GGRGSLRVEDVIKEGNNPLQQRIHRCGKGLPLLIFLPGPIDMEGGGGGGPTL.R
Innexin 4 ILKLLYKETNTQFSGSLVSVARQNEMNRYSMGDQGGITK
LOX2 PRQNMHLRRKADFSLYQRINISSHFDFTKPRKNCLASMTSR
LAR2 Ig domain VHHRGPSCGSDRPSGDCTRWYPRSPHTNSRIVNSVNSRNGSVSGHSVRAKHDKLMGSGD
QGKSIAMVESFRGQGPEGGLPSDPAPDVRAGRTKCNFQVFQLLLNGIGALNSRW.QSLRK
DSKSSLLVNAGSASQGKVNVAMR
Leech Ena DKAKQKGEDFENANCKLCWGSSACDVLPSLPAHSLAALTSPPPTPSFK
MS/MS analyses were performed by nanoLC/Trap after trypsin digestion. Identifications were performed by searching the Hirudo medicinalis EST databank and
Helobdella robusta genome and screening using INSPECT software.
doi:10.1371/journal.pone.0018359.t001
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of lipids present in the leech nerve cord during the course of
regeneration using molecular imaging by ToF-SIMS technology
(Figures 5 and 6). Besides ToF-SIMS imaging, a targeted
strategy was undertaken using MALDI-TOF to explore the
distribution of endocannabinoids (Figure 7) because of their
well-known involvement in mammalian brain regeneration
through vanilloid receptor activation [36–39].
Distributions of lipids in lesioned ganglia highlighted by
ToF-SIMS imaging. ToF-SIMS imaging of the leech nerve
cord enables the detection of a great number of lipids, including
lipids implicated in regeneration [40]. To explore how these
distributions change over time, we imaged lipids in the nerve cord
near the site of the lesion at different times after trauma (T0, T6 h,
T24 h) in order to assay changes that correlate with different
stages in the process of repair. Figure 6A presents the
Figure 4. DD-RP-HPLC of leech axotomized nerve cords acidic extracts at different times after connective nerve trans-section. After
prepurification by solid phase extraction, the 60% AcN eluted material is loaded onto a C18 column. Elution is performed with a linear gradient of
AcN (dotted line) and absorbance was monitored at 225 nm. Each individually collected peak is tested for its neurites outgrowth (example in upper
left insert) and antimicrobial (example upper right insert) activities. The peaks that showed temporal variation in intensity, whether they produced
antimicrobial or neurotrophic activity or not, are further purified and the peptides are identified by MALDI-TOF mass spectrometry and Edman
degradation. Sequence results and peptide identification are shown in Table 2.
doi:10.1371/journal.pone.0018359.g004
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modulated in the course of regeneration: oleic acid carboxylate,
mono-unsaturated omega-9 fatty acid (m/z 281.2), stearic acid
carboxylate (octadecanoic acid: m/z 283.2) and the PI38:4
phosphatidylinositol (m/z 886.5) [40]. At T0h (control,
Figure 6A), the patterns of expression of oleic and stearic acids
showed little overlap within the ganglion, but at T6 h, both lipids
were weakly expressed in the packet cells. By T24 h, stearic acid
showed stronger expression in the connective nerves and weaker
within the ganglion in comparison with oleic acid, which appeared
to accumulate in packet cells and be poorly expressed in the
connective nerves. The phosphatidylinositol ion was also detected
Table 3. Leech nerve cord proteins implicated in adult neuroregeneration using Proteomic (Bottom-up, DD-HPLC, 2D-Gel analysis)
and Transcriptomic approaches.
Protein Categories Bottom-up Strategy
2D Gel Proteomic
Strategy [9] DD-HPLC Strategy
Soustractive cDNA library
[3]
Cytoskeleton Microfilaments Tropomyosin Gliarin Protein 4.1
Intermediate filaments Filamin
Gliarin
Macrolin
Gliarin ReN3
Synapsin
Microtubules a &b tubulins
Calcium Calcium sensor NCS2
Neurocalcineurin
Calmodulin-like
Others
Metabolism AA/nt metabolism AA deshydrogenase ATPase inhibitor
Energy ATP synthase b unit
Acetyl tranferase
Hsp
&
Chaperones
Cyclophilin/
PPI
PDI
Cyclophilin
PDI
Others HSP 90
Metal
oxydation
Resp. molecules Neurohemerythrin
COX I
Myohemerythrin
COX I
Others
Immune effectors Cytokines Il-16
C1q
EMAP-II
CRIP
PAMs Neuromacin Hm-lumbricin
Neuromacin
Cathelicidin-like
Axonal guidance Ig-superfamily Tractin
Hillarin
Chemotrophic factors Netrin
Lena
Tyrosine phosphatase
receptor
LAR2 ectodomain
Morphogenesis Homeobox gene LOX2
Gap junction Innexin 4
(AA, aminoacyl; CRIP, Cysteine Rich Intestinal Protein; COX I, Cyclooxygenase I; nt, neurotransmitters; PPI, peptidyl-prolyl cis-trans isomerase).
doi:10.1371/journal.pone.0018359.t003
Table 2. Peptide sequences obtained after DD-HPLC, tested in neurite outgrowth or antimicrobial tests and sequenced by
automated Edman degradation.
Peak # m/z Sequences Biological Activities Blastp
1 3974 RRLPKFPKFPKFPKLPDWPQWPEWPQES Neurotrophic Hm-ABP3
2 6709 DXYEDWSRXTPGTSFLTGILXKDXSR Antimicrobial Neuromacin
3 6443 FSKYERQKDKRSYGERFS Antimicrobial Hm Lumbricin
4 11342 QXLGMSSSTIRREKTIQYGNAY Intermediate filament gliarin
5 13721 GFEIPEPYVRDEDFGVFYFNLDELH Neurohemerythrin isoform
6 13814 GFEIPEPYVWDESFKVFYENLDEXHKGLFQAIFN Neurohemerythrin
doi:10.1371/journal.pone.0018359.t002
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phosphate ion (PO3
2, m/z 79), which was broadly distributed in
nervous tissue (Figure 6B). After 6 hours of regeneration,
phosphatidylinositol appeared in cells near the connective nerve
that links the ganglion analysed to the ganglion anterior to the
lesion site, whereas at 24 hours of regeneration it was exclusively
localized in packet cells in the experimental ganglion.
Endocannabinoid involvement in nerve cord
regeneration. Along with these more global studies, we also
investigated a specific family of lipids, the cannabinoids, which are
known to be involved in neurogenesis as well [41]. We previously
established in leeches the presence of a fatty acid amid hydrolase and
monoglyceride lipase [42], and have shown some of their effects on
inflammation regulation [37,43,44]. We also demonstrated the
presence of the endocannabinoids anandamide (AEA, N-
arachidonoylethanolamine, 21.5+/20.7 pmol/g) and 2-arachi
donoylglycerol (2-AG, 147.4+/242.7 pmol/g), and of the
biosynthetic precursor of anandamide, N-arachidonylphosphatidyl-
ethanolamine (16.5+/23.3 pmol/g), in the leech central nervous
system (CNS). Anandamide-related molecules such as N-
palmitoylethanolamine (32.4+/21.6 pmol/g) and N-linolenoy
lethanolamine (5.8 pmol/g) were also detected. In this study, we
used MALDI-TOF and lithium adducts (see Methods) to detect the
release of AEA and 2-AG during regeneration. Analysis of temporal
changes in MALDI mass spectra showed an increase for AEA and 2-
AG signals, occurring within less than 15 minutes after the lesion
(Figure 7), reflecting a very quick release of these lipids. Both AEA
and 2-AG were present and peaked in the first hour (AEA at
,1 hour, 2-AG within minutes) in response to nerve cord damage.
This behavior is consistent with our previous demonstration that
these endocannabinoids can modulate leech brain inflammation
[38,42–45] and can act as chemoattractants for microglial cells
[43,46].
To assay for possible physiological activity of these cannabinoids
in regeneration, we conducted a series of in vitro studies with
several cannabinoid and vanilloid receptor agonists and antago-
nists. Specifically, nerve cord segments were placed in culture,
subjected to different concentrations of AEA, capsaicin, arvanil
and capsazepin, and checked for neurite outgrowth from a cut
connective nerve at various intervals after lesion (Figure 8). The
results show neurites sprouting from the cut nerve in less than a
week for the control preparations and in less than 3 days for
preparations exposed to either of the agonists, capsaicin and
arvanil, whereas no outgrowth was observed with exposure to
either of the antagonists tested, AEA and capsazepin. For the latter
molecules, a repair process has apparently occurred, since a brown
coloration can be observed that indicates a wound healing process
is taking place instead of neuronal regeneration.
Endocannabinoid effects are mediated by vanilloid but
not cannabinoid receptors in the medicinal leech. To
determine how the effects of release or exposure of
endocannabinoids might be mediated in the regenerating leech
CNS, we undertook a careful and thorough exploration of all
available leech transcriptomic and genomic databases for
orthologs of receptors known to bind these lipids. These
included the publicly available Hirudo sp. transcriptome [18] and
the Helobdella databases [47] as well as a Hirudo verbana genomic
database currently being assembled in our laboratory (T.
Gaasterland, private communication). This Hirudo genome
database was constructed using 73 M paired-end reads from
genomic DNA inserts of length 350 bases and 56 M single reads,
with reads of length 100 bases, obtained from libraries prepared
with DNA from two adult Hirudo verbena specimens and
sequenced on an Illumina Genome Analyzer IIx instrument.
The reads, containing a total of 12.9B unfiltered bases, were
filtered and errors corrected with Euler-NR sequence preparation
modules [48] and assembled with Velvet [49,50] using parameters
obtained through Velvet Optimizer [51]. The resulting 57,700
Table 4. Protein identification in time course of regeneration
processes based on complementary techniques (2D-Gel [7,9],
DD-HPLC, Bottom-up proteomic and soustractive DNA
libraries [3,21]).
Class of Proteins Protein Name 0 h 1 h 6 h 24 h 48 h
Immune Factors
IL-16, EMAP II X X X
Antimicrobial X X X X
C1q X X X
CRIP X
Cytoskeleton
Intermediate Fil. Filamin X X X
Gliarin X X X X
Macrolin X X X
Leech CAM X X X
Tractin X X X
Protein 4.1. X
Synapsin X X
ReN3 X
Microtubules Tubulins X
Axon Guidance
Ig Superfamily Hillarin X X
Leech ENA X X
Liprin X X
Chemotrophic F. Netrin X X X
Syntaxin X X X
Destabilase X X X X
TRP LAR2 e.d X X X
HSP&Chaperones
Cyclophilin X
PDI X
PPI X
HSP90 X
Metal oxydation
Neurohemerythin X X X X
COXI X X
Metabolism
AA/metabolism AA Deshydrogenase X X
ATPase Inhibitor X
Energy ATP Synthase X X
Morphogenesis
Homeobox gene LOX2 X X X
Gap Junction Innexins X X X
Calcium
Calcium Sensor NCS2 X
Neurocalcineurin X
Others Calmodulin-like X
doi:10.1371/journal.pone.0018359.t004
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contain 165 Mbp, and should include sequences of nearly all
medicinal leech genes.
Curated protein sequences for cannabinoid receptor (CB1 and
CB2) sequences available in GenBank were aligned against the
genome contigs using Tblastn and failed to detect any leech
Figure 5. ToF-SIMS analysis of lipids in a portion of control leech nerve cord, including a ganglion. A. Optical, transmitted light low-
resolution image of unstained tissue (ganglion and parts of attached nerve) prior to ToF-SIMS analyses. The ganglion is placed in gelatin before being
sectioned at 10 mm. The slices are deposited onto silicium target. B, C. Tissue distributions of two ions, m/z 184.1 and m/z 369.32, corresponding to
the phosphocholine ion and to the cholesterol fragment ion [M+H-H2O]
+, respectively. The phosphocholine ion can be observed mainly in the outer
areas of the ganglion, where neuronal somata and glial packets are located, while the cholesterol fragment ion is also found throughout the central
neuropil. Five adjacent individual images of 5006500 mm
2 where assembled end-to-end to create these images. Color scale bars, with amplitude in
number of counts, are indicated to the right of each ion image. The amplitude of the color scale corresponds to the maximum number of counts mc
and could be read as [0, mc]. tc is the total number of counts recorded for the specified m/z (sum of counts in all the pixels).
doi:10.1371/journal.pone.0018359.g005
Table 5. Leech Brain phospholipases and lipoxygenases obtained from Hirudo medicinalis nerve cord EST library (http://www.cns.
fr/spip/Hirudo-medicinalis-collection-d.html).
Contig Number Protein Homology e Value
EN-133k-group2267.Contig1 Phospholipase D3 (EC 3.1.4.4) (PLD 3) (Choline
phosphatase 3)
Bos taurus 1e
2100
EN-133k-group1648.Contig4 Phospholipase A2, group IVB (Cytosolic) Xenopus tropicalis 1.3 e
274
EN-133k-group574.Contig2 calcium-independent phospholipase A2(iPLA2) Mus musculus 1.4 e
259
EN-133k-group179.N_gs_28394 Lysophospholipase Argas monolakensis 6.2e
259
EN-133k-group11049.Contig1 Phospholipase C Aplysia californica 9.7e
251
EN-133k-group12326.N_gs_44143 Phospholipase D Aedes aegypti 2.5e
248
EN-133k-group501.Contig1 Arachidonate 15-lipoxygenase type II Mus musculus 9e
247
doi:10.1371/journal.pone.0018359.t005
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has been reported in other invertebrates. Mammalian sequences
from another group of receptors reported to bind endocannabi-
noids, the Transient Receptor Potential Vanilloid (TRPV)
receptors, were then used as query sequences. Tblastn alignments
[52] identified two distinct full length putative medicinal leech
Figure 6. ToF-SIMS lipid ion images of leech ganglia in course of regeneration. A. Drawing of the structure of ganglion (upper left of the
panel) [19]. Optical, transmitted light low-resolution images of control, 6 h and 24 h regeneration ganglia included into gelatin 10% before sectioning
(lower left of the panel). Highlighting the changing distributions of oleic acid carboxylate (m/z 281.2), stearic acid carboxylate (m/z 283.2) and
phosphatidylinositol PI34:2 (m/z 885.5) in these ganglia in course of regeneration by ToF-SIMS imaging (right of the panel). Color scale bars, with
amplitude in number of counts, are indicated on the right margin of each ion image. The amplitude of the color scale corresponds to the maximum
number of counts mc and could be read as [0, mc]. tc is the total number of counts recorded for the specified m/z (sum of counts in all the pixels). B.
Lipid ion images (color overlays) of leech ganglion in course of regeneration (0:control, 6 h and 24 h regeneration). (1) Oleic acid carboxylate (m/z
281.2), stearic acid (m/z 283.2) and phosphatidylinositol PI34:2 (m/z 885.5) and (2) Phosphatidylinositol (m/z 885.5) and phostate (m/z 78.9).
doi:10.1371/journal.pone.0018359.g006
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in Helobdella. A third partial protein fragment with an ankarin
repeat domain was identified in Hirudo and may represent a third
Hirudo TRPV. Exons were extracted from contigs and concate-
nated to form HmTRPV1-3 shown in Figure S5. A partial
transcript for HmTRPV1 was also found in the Hirudo transcrip-
tome database [18]. An evolutionary comparison (Figure 9)
shows that the Hirudo TRPVs are diverged from mammalian
TRPVs, as are the related OSM1 and OSM3 proteins from C.
elegans and D. melanogaster.
On the basis of these findings, we propose the hypothesis that
CNS regeneration involves endocannabinoids acting through
leech vanilloid receptors. This hypothesis is currently being tested
and the results will be reported in a subsequent publication.
Discussion
The medicinal leech is a very interesting model system for the
study of the mechanisms of neural regeneration because of the
capacity to regenerate the CNS throughout its life. The continued
presence of embryonic factors necessary for neuronal growth and
maturation and the ability to induce expression or repression of
critical factors in response to signals released by damaged tissues
are possible explanations for this useful property.
Another aspect of these animals is the continuous expansion of
their central neurons. This suggests that the machinery for growth
and addition of synaptic coupling may never be turned down or off
completely in leeches, in contrast to mammals, in which not only
are many embryonic growth-promoting molecules and their
receptors apparently no longer present in the adult, but the adult
CNS produces various growth-inhibiting molecules that are not
present in the embryo or neonate [53]. Comparison of the
mechanisms of regeneration in leeches and mammals should yield
some insight into which components might be artificially
modulated, and how, in order to enhance regeneration in the
mammalian nervous system.
The observations reported and discussed here were conceived as
a starting point for applying MALDI imaging to the discovery of
the protein and lipid components involved in the process of neural
regeneration in the medicinal leech model system. MALDI
imaging analyses provided an initial overview of the presence,
abundance and distribution of many peptides/proteins in the
range m/z 1,000 to 30,000 in regenerating versus control adult
ganglia (Figure 1) and in the surrounding blood sinus (Figure 3).
Figure 7. Levels of cannabinoids change as a function of time after injury. Time course MALDI-TOF measurement of cannabinoids in injured
nerve cords from time 0 to time 240 minutes. A. Levels of 2-AG and 2-AG deuterated (D2O) with lithium chloride addition after the nerve cord lesions.
B. Levels of AEA and AEA deuterated (D20) with lithium chloride addition after nerve cord crush. C. MALDI-MS spectra of standards of 2-AG and 2-AG
with lithium chloride addition. D. MALDI-MS spectra of standards of AEA and AEA with lithium chloride addition.
doi:10.1371/journal.pone.0018359.g007
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location contain hundreds of peaks that might be of interest, and a
criteron for selecting those that warrant further study needs to be
formulated.
In our case, this criterion is the presence of a significant
difference in the abundance (area under a peak) of the
corresponding factor between the normal and the regenerating
states. One way to analyze the massive amount of data produced
by MSI and facilitate the identification of m/z values worthy of
further study is to subject MSI datasets to PCA and clustering.
When applied to the regenerating leech adult ganglia and blood
sinus datasets, this analysis yielded two interesting results:
(1) A heterogeneous distribution favoring the presence and
abundance of some of the clusters in the region of the ganglion
proximal to the mechanical trauma (nerve crush), which we
interpret as evidence for the accumulation of factors that are
required by the process of regeneration in the damaged area.
(2) An apparent migration of blood molecular components into
the CNS from the adjacent sinus, as denoted by the changes in
cluster localization, indicating that blood-born peptides/proteins
also migrate towards the site of damage.
Moreover, correlation between non targeted (MALDI imaging
mass spectrometry) and targeted (DD-HPLC coupled to antimi-
crobial and neurotrophic tests) strategies showed that two of the 6
identified peptides (m/z 12,721, 13,684) corresponding to
neurohemerytrin isoforms have been localized in the leech ganglia
by MALDI-MSI. However, from the 21 detected by MALDI-MSI
in the whole of ganglion, only four have been identified by DD-
HPLC and bottom-up strategies. This last point show that it is now
important to develop common experimental procedures and to
create some new software [10] allowing such correlation between
MALDI-MSI studies coupled to PCA and classical peptidomic/
proteomic analyses. The power of MALDI-MSI is the ability to
have access of a great number of peptides/proteins in non-targeted
approach like classical proteomic, but establishing the spatial
localization of the molecules in the tissues and getting access to the
dynamic of the proteome in the organ.
While many of these peptides/proteins are probably house-
keeping and general maintenance molecules that are required to
reconstruct the damaged tissues, we expect that some will be
specialized signals, neurotrophic and guidance factors, and neuro-
specific molecules that are key to the re-establishment of a unique
network of connections. It is the latter that we are particularly
interested in identifying among the many m/z values present in the
dataset.
Our data confirm the presence, and in some cases the up- or
down-regulation, of different functional groups of proteins in the
regenerating adult leech brain that are also expressed at significant
levels in the embryonic CNS (Tables 1–3; [3,7,9]). Among these
are proteins implicated in cytoskeletal remodeling, including the
Intermediate Filament (IF) proteins Gliarin and Macrolin [54] and
the actin-binding protein Filamin [26]. Both ifs contain the coiled-
Figure 8. Cannabinoids affect neurite outgrowth from cut nerves in cultured segments of the CNS. In vitro leech nerve cord culture and
neurite outgrowth assays with arvanil, capsaicin, capsazepin at concentration of 10
25Mo r1 0
27M. Neurite outgrowth is indicated as well as the ones
non regenerating.
doi:10.1371/journal.pone.0018359.g008
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unique N- and C-terminal domains, but Gliarin is found in all glial
cells, including macro- and microglial cells [9,54], whereas
Macrolin is expressed in only a single pair of giant connective
glial cells [54]. Interestingly, the m/z 2475 ion we selected for
further study because it is present in embryonic ganglia and up-
regulated in the adult CNS following injury (Figure 2, Figure
S1), has been recently identified as a new member of the IFs,
HmIF4 [10]. In contrast to Gliarin and Macrolin, HmIF4 appears
to be highly expressed in neurons [10]. Filamin, with two calponin
homology domains and 35 filamin/ABP-repeat domains, has been
implicated along with Tractin in muscle development and nerve
formation [26].
Another interesting functional group of proteins identified in
this proteomic study as potentially involved in both neural
development and regeneration is comprised of several neural
members of the Ig superfamily (IgSF), specifically Tractin, Hillarin
and the receptor tyrosine phosphatase HmLAR2. Related to the
last of these, we have recently reported that HmLAR1, a sibling
RPTP of HmLAR2, is upregulated in specific neurons in response
to a nerve crush, and that the regeneration of severed axonal
projections is significantly impaired when RNAi is used to block
this upregulation [29] Tractin and LeechCAM have been
implicated in neurite outgrowth in the course of neurogenesis by
Johansen, Zipser and collaborators [24,26,27,55,56]. Tractin is
widely expressed and is differentially glycosylated in sets and
subsets of peripheral sensory neurons that form specific fascicles in
the central nervous system. Additional proteins identified in this
screen that appear to be involved in neural regeneration include
several previously identified in leech brain, including Netrin [28],
Hillarin [57], and Lena (leech homolog of Enabled) [58]. Hillarin
is localized to the axon hillock of leech neurons and affects cell and
axonal cytokinesis through its interactions with septins [25,59].
Lena, a cytosolic protein implicated in actin-based cell motility
[58] has been shown to associate in the leech with the HmLAR
receptors, whose ectodomains are thought to promote an adhesive
interaction that enhances neuronal sprouting [60].
An interesting and somewhat unexpected among our observa-
tions is the adult expression of the homeobox gene LOX2, which
in the embryo is expressed in 25–30 pairs of neurons repeated in
the posterior two-thirds of the midbody ganglia [61,62]. Possibly
this transcription factor regulates a set of specific growth responses
that are triggered by neuronal damage, a hypothesis that has not
been tested experimentally at this time.
Of particular novelty is the dynamic expression of three
antimicrobial peptides in leech brain (Figure 4, Table 2)a sa
result of mechanical injury: Hm-neuromacin, Hm-lumbricin [14],
and the novel one, HmAMP3. These antimicrobial peptides
produced by neurons and microglia have been recently shown by
our group to promote the regeneration of neurites in axotomized
leech CNS [14], indicating that they have multiple functional roles
in the CNS. Moreover, other immune factors appear to also
participate in the neuroregenerative process. We recently
demonstrated that several leech CNS immune factors identified
Figure 9. Phylogenetic tree showing Hirudo, Helobdella, mouse, rat, Human TRPVs and C. elegans, D. melanogaster OSMs. Leech TRPVs
are slightly less diverged from mammalian TRPVs than those of C. elegans and drosophila and are closest to mammalian TRPV5 and TRPV6. (ce,
Caenorhabditis elegans; dm, Drosophila melanogaster; hm, Hirudo medicinalis; hr, Helobdella robusta; hs, Homo sapiens; mm, Mus musculus; rn, Rattus
norvegicus).
doi:10.1371/journal.pone.0018359.g009
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IL-16 [12] as well as the complement factor C1q [13], exert
chemotactic effects towards leech microglia. In mammals, C1q is
known to be synthesized and released by activated microglia in
order to maintain and balance microglial activation in diseased
CNS tissue [63].
Neuroinflammation is another key aspect of the neuroregen-
erative process. Molecules related to cyclophilin, ERp60 [9] in
conjunction with cytokines like those related to IL-16, IL-17 and
IL-25, are implicated in the control of inflammation [64–68] and
the presence of such molecules in leech CNS [12,18] after trauma
suggests a generality and convergence of such a biological
phenomena at early stage of the regeneration process. Neuroin-
flammation seems to be necessary for initiating microglial
activation [69,70], but it needs to be then controlled in order to
block the apoptotic loss of neurons which may occur following
excessive brain inflamation. This could be mediated by specific
lipids that participate in the regulation of neuroinflammation,
including cannabinoids and omega lipids [16,19]. As we observed
through in vivo and in vitro experiments, triacyl-sn-glycerols (C10,
C14, C16), and omega lipids are synthetized as an early response
to the lesion, in conjunction with endocannabinoids (AEA and 2-
AG). These factors act as neuroimmunomodulators [71] and in
the limited regeneration [72] in the mammalian spinal cord. The
fatty acids are the targets of cerebral lipoxygenases that release
very powerful anti-inflammatory factors, such as the neuropro-
tectins or the resolvins. In the series v6, arachidonic acid is
produced by all cells from the action of phospholipases and is the
precursor of several neuroprotective agents, such as the endocan-
nabinoids, which are synthesized in the brain and have anti-
inflammatory properties. The major lipid in the v9 series is oleic
acid (C18:1), which also protects the nervous system by blocking
the resulting inflammation after excessive stimulation (exitotoxi-
city). Sulfatides and gangliosides constitute another class of lipids
preserving the central nervous system in vertebrates. Some studies
have shown that their diminution at the cerebral level is directly
associated with the manifestation of neurodegenerative conditions
such as are observed in Alzheimer’s disease [73–75]. In our
context, stearic acid and phosphatidylinositol, as well the mono-
unsaturated omega-9 fatty acid (oleic acid) are produced early
after trauma and each show a specific pattern of expression,
spatially and temporally. At the level of the trauma, oleic acid and
phosphatidylinositol migrated from connective to neurons (packet
cell) whereas stearic acid accumulate in connective and less in
ganglion. This can be explained by the fact that oleic acid
regulates inflammation at the level of neurons [76] whereas stearic
acid seems to play a role in tissue repair and plasticity, near the
lesionned connective [77,78].
We propose that these data can be thought of together through
the following model. Cannabinoids are more implicated at later
stages of the regeneration/repair process. In fact, the neurite
outgrowth tests showed that, among them, AEA is more important
in scar formation whereas 2-AG appears to be more involved in
axon extension. Cannabinoids are part of the regeneration process
along with peptides and proteins, and all need to be taken into
account together to achieve a deeper understanding of the whole
of the biological process. In addition, microglial cells, in
conjunction with neurons and blood cells are able to regulate
neural inflammation very quickly and to stimulate neurite
outgrowth, also with the release of cannabinoids, which at later
stages appear to act along gangliosides in apoptosis regulation,
neurite outgrowth and the release of axonal guidance factors. In
the same time window, 3 hours after lesion, embryonic factors re-
expression possibly occurs through homeobox gene activation,
axon guidance and neurotrophic factors released. This is also
linked to a close interaction between cells and the implication of
intermediate filaments and cell-matrix interactions performing a
net where neurites are able to sprout and receive some positive and
negative factors like neuroregulins (erb-2 like factors, Cuvillier-
Hot, unpublished data), inhibitors of NOGO and inhibitory
factors.
In summary, proteomic and lipidomic approaches were
employed to profile and identify different lipids and proteins in
leech embryos as well as normal and regenerating adult leech
nervous system. These are proposed as strong candidates for
important roles in the mechanisms of neural regeneration
(Table 4). The overlap between these profiles observed in
regeneration in response to physical damage and in the
neuroimmune response to bacterial insult suggests that these
complex dynamic processes, involving many different types of
cells and mediators, have much in common. Moreover, the
overlap between molecular profiles observed in neural develop-
ment and adult regeneration suggests that a significant recapit-
ulation of neurogenic programs is present in the course of
regeneration. The data presented here is only a beginning, but it
already identifies similarities between the molecular underpin-
nings of invertebrate and vertebrate responses to trauma,
similarities that can be exploited in furthering our understanding
of the reasons for the limited capacity to regenerate neurites in
the mammalian CNS.
Materials and Methods
Reagents
Alpha-cyano-4-hydroxycinnamic acid (CHCA), Sinapinic acid
(SA), Trifluoracetic acid (TFA), Formic acid, Hydrochloric acid
(HCl), Acetonitrile (AcN), Acetone, Ethanol (EtOH), Methanol
(MeOH), Water CHROMASOLV PLUS for HPLC (H2O),
Chloroform (CHCl3), Aniline (ANI), 2-Arachidonyl glycerol (2-
AG), Lithium chloride, Ammonium bicarbonate (NH4HCO3)
were purchased from Sigma-Aldrich (Saint-Quentin-Fallavier,
France). Anandamide (AEA) was obtained from Merck Chemicals
(Nottingham, UK). Sequencing grade modified trypsin, porcine
enzyme was from Promega (Charbonnie `res-les-Bains, France).
Animals
Leech embryos (E12 stages) and adults used in these
experiments were obtained from Hirudo medicinalis/Hirudo verbana
colonies maintained in our laboratories. Prior to use, embryos
were removed from their cocoons and kept in artificial spring
water (0.5 g/l Instant Ocean, Aquarium Systems) at 22uC, and
staged according to the criteria of Fernandez and Stent [79]. At
this temperature, day 0 (E0) is defined as the day of cocoon
deposition and day 30 (E30) as the day of emergence of the
juvenile animal from the cocoon.
Sampling
All adult medicinal leeches sp. were purchased from Ricarimpex
(Eysines, France). After arrival, leeches were kept without further
feeding in artificial pond water until dissection. To produce
controlled CNS lesions,following the procedure of Nicholls et al.
[80], animals were pinned ventral-side up and small windows
opened along the ventral midline in order to gain access to and
partially cut the interganglionic connectives. After allowing a
period for recovery and the establishment of a regenerative
response (6 hours to 7 days), nerve cords were completely removed
from the animals.
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Differential Display HPLC (DD-HPLC). Nerve cords
collected at different time of regeneration processes (20 nerve
cords/time plot) were homogenized in phosphate buffered saline
pH 7.5. Liquid was immediately centrifuged at 10,000 g at 4uC
for 20 min and the supernatant was acidified by adjusting the pH
to 3.9 with 1 M HCl. Centrifugation (10,000 g at 4uC for 20 min)
was then used to clarify the supernatants, which were loaded onto
Sep-Pak C18 Vac cartridges (Waters). Elution steps were
performed with 2% and 60% AcN in H2O/0.01% TFA. The
pre-purified fractions were then lyophilized, reconstituted in pure
water and tested for neurite outgrowth activity. Only the 60%
AcN eluted fractions were active and submitted to purification by
reversed-phase high pressure liquid chromatography (RP-HPLC).
All the purification steps were carried out on a Beckman
TM Gold
HPLC system. The 60% Sep-Pak fractions collected at each time
plot of regeneration were subjected to RP-HPLC on a Sephasyl
C18 column (25064.1 mm, 218TP54 Vydac
TM). Elution was
performed with a linear gradient of 2-62% AcN in acidified water
over 90 min at a flow rate of 1 ml/min. Fractions corresponding
to absorbance peaks were collected in polypropylene tubes,
lyophilized, reconstituted in water and tested for neurite
outgrowth activity tests (see below). Experiments were conducted
3-times.
For peptides identification, each fractions presenting a nerve
sprouting activity were further loaded onto a C18 column
(25062.1 mm, 218TP52 Vydac
TM) with a gradient consisting in
2–25% AcN in acidified water for 10 min and 25–35% AcN for
40 min at a flow rate of 0.2 ml/min. Fractions were collected and
treated as above. One additional step was performed on a narrow
bore C18 reversed phase column (15062 mm, Waters) at a flow
rate of 0.2 ml/min using the AcN gradient described in the step 2.
The purity assessment and the molecular mass determination of
the peptides were carried out by Ultraflex II MALDI-TOF/TOF
instrument (Bruker Daltonics, Bremen, Germany). N-terminal
sequencing of the purified peptides was performed by automated
Edman degradation on a pulse liquid automatic peptide
sequenator (Beckman).
Peptides quantification has been carried out on lots of 20 nerve
cords. Each lot was first weighed and then was submitted to the
same procedures before being subjected to the Sep-Pak prepur-
ification. Bradford quantification of each lot was performed before
injection onto the RP-HPLC. Each collected peptide was tested on
antimicrobial and neurotrophic tests activities and compared to
internal standards [14,15].
Neurotrophic activity assays. Dissected nerve cords were
placed in 35 mm Petri dishes with 1 ml Leibovitz L-15 medium
(Gibco, Invitrogen, USA) complemented with 2 mM L-glutamin,
0.6% glucose, 10 mM HEPES (complete medium), 10% Fetal
bovine serum and antibiotics (100 UI/ml penicillin, 100 UI/ml
streptomycin and 200 nM/ml gentamycin).
Neurite outgrowth in response to exposure to peptidic fractions
purified by chromatography was measured in disocciated cultured
leech neurons. Briefly, neurons mechanically dissociated from 3
nerve cords, were resuspended in 10 ml of L-15. Isolated neurons
were split into the 96 wells of a culture plate and were then
maintained at 20uC for one day before 10 ml of each RP-HPLC
fraction were added to the 100 ml of culture medium. Neurite
outgrowth of individual cells was quantified daily, up to 3 days
after the addition of individual fractions to the culture, using the
LEICA DMIRE2 inverted microscope (Leica Microsystems,
Nanterre, France). Experiments have been conducted 5-times.
Antibacterial activity assays. After each purification step,
antibacterial activity was monitored by a solid plate assay as
described in previous studies [81]. The minimal inhibitory
concentration and the minimal bactericidal concentration were
determined according to the published method of Hancock, which
is available at http://cmdr.ubc.ca/bobh/showmethod.php
(method id_79).
Bottom-up strategy. Nerve cords collected at different times
after lesioning (20 nerve cords/time plot) as well as embryos (E12
stages) were homogenized in phosphate buffered saline pH 7.5.
Liquid was immediately centrifuged at 10,000 g at 4uC for 20 min
and the supernatant was acidified by adjusting the pH to 3.9 with
1 M HCl. Centrifugation (10,000 g at 4uC for 20 min) was then
used to clarify the supernatants, which were loaded onto Sep-Pak
C18 Vac cartridges (Waters). Elution steps were performed with
2% and 80% AcN in 0.01% TFA. The 80% pre-purified fractions
were then lyophilized, reconstituted in pure water and titrated in
Bradford before submitted to trypsin digestion.
In order to achieve the trypsin digestions, samples (extracted
proteins) were placed, after drying, on ice for 30 min in 50 mlo f
trypsin solution (0.02 mg/ml in 25 mM NH4HCO3). Digestion
was then allowed to proceed overnight at 37uC. The reaction was
stopped by the addition of either 50% AcN/1% TFA for further
MALDI-MS analysis or 50% AcN/1% formic acid for further
ESI-MS/MS analysis. Trypsin digests were then lyophilized in a
SpeedVac concentrator. For nanoLC-MS/MS identification,
peptides were re-dissolved in H2O/MeOH 0.1% formic acid
(9:1 v/v) after elution and evaporation.
NanoLC-ESI-IT MS and MS/MS analyses were performed on
an ion trap mass spectrometer (LCQ deca XP plus, Thermo
electron) equipped with a ESI ion source and on-line coupled to a
nano HPLC system (Ultimate, Dionex). 0.5 mL of digest were
injected with a Switchos Autosampler (Dionex corporation) and
separation performed on a C18 silica bonded stationary phase
(75 mm i.d., 150 mm long, 3 mm 100 A ˚ pore size, Dionex).
Samples were washed for 2 minutes at 10 mL/min with 100%
mobile phase A (95% H2O, 5% ACN 0.1% formic acid). Peptides
were then eluted using a linear gradient of 1%/min mobile phase
B (ACN 80%, H2O 20%, formic acid 0.08%) for 70 minutes at a
flow rate of 0.2 mL/min. The LCQ deca XP plus was operated in
a data dependent MS/MS mode in which one MS full scan was
followed by one MS/MS scan on the most abundant peptide ion.
Collision energy was set to 35%. The heated capillary temperature
and electrospray voltage were 160uC and 1.5 kV respectively.
Protein identification was performed with the Phenyx (Genebio)
sequence query search program using the leech EST (http://
genomes.ucsd.edu/leechmaster/transcriptome-paper/) and geno-
mic (http://genome.jgi-psf.org/Helro1/Helro1.home.html) data-
bases filtered for the taxonomy ‘‘Hirudo medicinalis and Helobdella
robusta.’’ A tolerance of 1 Da for peptides in MS and 0.5 Da for
MS/MS was used. Only peptides sequences with a MOWSE score
higher than 32 (indicating significant homology or identity) and
identified in several samples were considered. Methionine
oxidation was defined as the variable modification.
MALDI imaging of Proteins. Leech nerve cords were
included into gelatine 10% instead of OCT before sectioning.
Thin 10 mm tissue sections were obtained using a cryostat Leica
CM1510S (Leica Microsystems, Nanterre, France) and mounted
onto ITO-coated conductive glass slides (Bruker Daltonics,
Bremen, Germany). Several research groups have demonstred
that the realization of chemical treatment on the tissue section can
improve the quality of MS spectra. As described by Lemaire and
co-workers, a washing step using chloroform allows to mainly
remove phospholipids which can interfere in the spectra when
analysing peptides [82]. Caprioli et al. showed the use of alcohol to
fix the tissue and remove lipids and salts which can create a poor
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to a washing step using cold EtOH 70% then cold EtOH 95%
during 30 seconds for each bath followed by a washing step using
chloroform during 30 seconds.
For matrix deposition, an ionic matrix solution containing
10 mg/ml of SA and 1 equivalent of ANI in AcN/TFA 0.1%
(7:3,v/v) was prepared. The matrix was deposited on leech tissue
section with the automatic sprayer Imageprep (Bruker Daltonics,
Bremen, Germany), which creates an aerosol by vibrational
vaporization and provides high resolution images. For an optimal
matrix coating the different steps i.e. spraying, incubation, drying
and matrix-layer-thickness were monitored in real time. The
method used here for SA/ANI deposition was a home-made
method composed by an initialization phase in order to deposit a
first layer of matrix on the slide followed by phases allowing a good
co-crystallization of matrix crystals and analytes thanks to
alternating cycles of partial and complete drying.
Image acquisitions were performed using an UltraFlex II
MALDI-TOF/TOF instrument (Bruker Daltonics, Bremen,
Germany) with a resolution of 50 mm in positive linear mode.
Three hundred MALDI-MS spectra were acquired at each
position in the mass range from 2000 to 20000 Da using a laser
frequency of 50 Hz. Recording and reconstruction of the images
were performed using FlexImaging 2.1 (Build 15) software (Bruker
Daltonics, Bremen, Germany).
The normalization of MALDI images is a data processing that
does not work on the single spectra, but on the dataset as a whole.
The aim is to equalize the total ion count for all spectra. This is
done to counter the effect of ‘‘hot spots’’ on the image. A hot spot
could e.g. be a large matrix crystal, that was hit directly by the laser
beam, resulting in a higher spectrum intensity at this point. The
normalization has the disadvantage of artificially increasing the
intensity of pure noise spectra. It is therefore possible to exclude
noise spectra by defining an Ymean/Ymax cutoff. Normalization is
performed according to the calculation:
Ymean~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
y1
2zy2
2zzyn
2
n
r
y = y value at a point of the spectrum and n = number of data
points of the spectrum.
If Ymean , Threshold Factor * max. value of y-axis, then the
spectrum will be normalized.
Each MALDI imaging experiments have been conducted 5
times.
Lipidomics Methods
Endocannabinoid quantification. Endocannabinoid level
measurement was performed in course of regeneration by
MALDI-TOF mass spectrometry. 24 isolated nerve cords at 6
different time course of regeneration from 0 to 240 min were
collected in physiological saline. Each set of 4 nerve cord sections
(three ganglia and three connectives) was used to titrate the
anandamide (AEA) and 2-arachidonoylglycerol (2-AG). Internally
deuterated anandamide (4 mg/mL) and 2-arachidonoylglycerol
(4 mg/mL) were added to each set before lipid extraction. From
each set, the Folch method (chloroform/methanol (3:1;v/v)) was
performed for total lipid extraction. The chloroformic phase
containing endogenous and deuterated endocannabinoids was
harvested and submitted to a relative quantification.
For MALDI-TOF MS, lithium salt combined with DHB in
acetone is known to be effective for determination of nonpolar long-
chain lipids, hydrocarbons and polymers by MALDI [84]. Under
these conditions, 3 mg of lithium chloride salt with 6 mg of 2,5-
DHB were dissolved in 100% acetone. Lithiated matrix and lipid
extracts (1:1;v/v) were mixed and dropped onto a 384 stainless steel
sample plate (Bruker Daltonics Bremen, Germany). Mass spectro-
metric analyses were performed in positive reflector mode with an
UltraFlex II MALDI-TOF/TOF instrument (Bruker Daltonics,
Bremen, Germany) equipped with a Smartbeam laser having a
repetition rate up to 200 Hz and controlled by FlexControl 3.0
(Build184) software (Bruker Daltonics, Bremen, Germany). The
spectra were treated with FlexAnalysis 3.0 (Build 96) software.
Linearity of the mass spectrometry measurements was determined
with endocannabinoid standards by measuring the ratio of their
accumulated (8000 laser smartbeam shots) area spectra over the
corresponding internal deuterated standard one. The measure-
ments obtained for accumulated spectra showed linear responses
within the referenced range. Relative quantification of 2-AG and
AEA was performed by stable isotope dilution (2-AGd8 and
AEAd8). The presence of 2-AG and AEA was determined by
observing that their respective ions of m/z 385.29 and 354.29 were
isolated and fragmented according the positive LIFT mode of the
MALDI-TOF mass spectrometer and compared to their corre-
sponding standards. Experiments were conducted 3-times.
Physiological activity of endocannabinoids. For neurite
outgrowth assay, dissected nerve cords (three per condition) were
pinned in a dish coated with silicone rubber (Sylgard 184)
containing supplemented L-15 medium under sterile conditions
[12]. To investigate the process of neurite outgrowth, one lateral
connective nerve was cut in each nerve cord and drugs (AEA,
capsacin, aravanil, capsazepin) were added to the culture medium.
Controls consisted of the absence of drugs. Images of the cut ends
were taken every 24 hours for 1 week (objective X5) using an
inverted microscope (as described above) and analyzed using the
Bioposition V3.0 software (developed on the Matrox MIL7.5 Base
Library by Gilles Courtand, Centre Commun de Mesures
Imagerie Cellulaire, University of Lille, France).
ToF-SIMS imaging. Leech nerve cords in course of
regeneration (0, 6 hours, 24 hours as described above) were
included into gelatine 10% instead of OCT before sectioning.
Thin 10 mm tissue sections were obtained using a cryostat Leica
CM1510S (Leica Microsystems, Nanterre, France) and mounted
onto silicon wafer before analyzed by ToF-SIMS.
A standard commercial ToF-SIMS IV (Ion-Tof GmbH,
Mu ¨nster, Germany) reflectron-type ToF mass spectrometer was
used for MSI experiments. The primary ion source was a bismuth
liquid metal ion gun. Bi3
+ cluster ions were selected. The ion
column focusing mode ensured both a 122 mm beam focus and
short pulse duration of less than 1 ns. Such short pulses are a
prerequisite for high mass resolution, accurate mass measure-
ments, and structure assignments. Because of the very low initial
kinetic energy distribution of the secondary ions, the relationship
between the time-of-flight and the square root of m/z is always
linear over the whole mass range. The mass calibration was always
internal and signals used for initial calibration were those of H
+,
H2
+,H 3
+,C
+,C H
+,C H 2
+, and CH3
+ for the positive ion mode
and the signals of C
2,C H
2,C 2
2, and C2H
2 for the negative ion
mode. Signals of cholesterol were used for the positive ion mode
calibration refinement, and for negative ion mode, fatty acid
carboxylate ions were selected. Structure attributions or assign-
ments of ion peaks were made according to the instrument
resolution (M/DM =10
4, full width half-maximum [fwhm], at m/
z 500), accuracy, and the valence rule. A more detailed description
can be found elsewhere [85]. Molecular images were recorded
with a field of view of 5006500 mm
2 and 2566256 pixels, giving a
pixel size of 262 mm
2. In these conditions, the fluence was always
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22. A low energy electron flood gun is
activated between two primary ions pulses in order to neutralize
the sample surface with the minimum damage. The m/z value of
the peak centroid, the maximal number of counts in a pixel (mc)
and the total number of counts (tc) are written below each image.
The color scales correspond to the [0, mc] intervals. The data
acquisition and processing softwares were IonSpec and IonImage
(ToF-SIMS software V4.1, Ion-Tof GmbH, Mu ¨nster, Germany).
Genomic and Transcriptomic Methods
Two TRPV sequences were identified through homology-based
alignment between mammalian TRPV protein sequences and six-
frame translations of contiguous DNA sequences (contigs)
assembled from high-throughput short-read sequences. The draft
genome contigs were obtained by assembling a total of 73 million
paired-end reads and 56 million single reads, all of length 100. A
separate, single animal was used to prepare DNA for sequencing
libraries. Assembly was performed with EULER-SR, Velvet
Optimizer, and Velvet [18,48–50] Human, mouse and rat protein
sequences for TRPV1-6 were downloaded from the Uniprot
Database [86,87] and subjected to alignment with contigs using
the Tblastn algorithm [52]. (Note, rat TRPV3 is missing from the
curated databases). Protein subsequences translated from aligned
contig subsequences and the alignment coordinates were extracted
from tabular blast output; corresponding DNA subsequences were
extracted from contigs. Protein and DNA sequences were joined
with custom perl scripts into putative Hirudo protein and their
coding sequences (CDS). The Hirudo proteins were aligned with
proteins downloaded from the Helobdella genome website [47] and
expressed sequences from the Hirudo transcriptome [18] to obtain
two Helobdella TRPV orthologs and confirm expression of TRPV2
in Hirudo. Hirudo and Helobdella proteins were aligned with the
protein database at GenBank to confirm that TRPVs were the best
matching proteins in human, and OSM1 proteins were the best
matches in C. elegans, D. melanogaster, and other insects. TRPV and
OSM proteins from leech, Human, mouse, rat, worm, and fly
were multiply aligned with clustalw [88] and trees generated from
distances output by clustalw.
Supporting Information
Figure S1 The m/z 2475 ion is not expressed in control
adult CNS segmental ganglia. A. MALDI-MS average
spectrum acquired from 9 sections of the non regenerating adult
ganglion. The ion with m/z 2475 is not detected in control ganglion
sections (labeled by the red cross). B. Distribution of the m/z 2475
ion in sections of the non regenerating adult ganglion. The insert
shows a magnified image of the data for section 4, with the
abundanceoftheioncolorcoded according tothecolorbaratright.
(TIF)
Figure S2 Hierarchical clustering of spectra from 9
sections of a control ganglion and surrounding blood
sinus. A. Full dendrogram of all spectra in the ganglion dataset
yields two main branches, colored red and green, that segregate
into different domains in the images, (panel B). B. Reconstruction
of selected dendrogram branches and corresponding images shows
that the lower branch (green) corresponds with the blood cells
(annulus around the central region) while the upper branch (red)
corresponds to cells in the CNS region. In all sections, the blood
sinus peptide profile (green) appears to be separate from the CNS
peptide profile (red).
(TIF)
Figure S3 Sequence alignment of proteins present
during neurogenesis and regeneration. The peptides
obtained by shot-gun were balst against Hirudinae EST library
using Blast-P.
(TIF)
Figure S4 Leech nerve cord peptides and its differential
distribution in crush direction using MALDI-MS imag-
ing approach. Each 10 mm thick section is spaced about 20 mm.
(TIF)
Figure S5 Coding DNA and amino acid sequences for
Hirudo TRPV1, TRPV2, and putative partial TRPV3
fragment. DNA sequences were extracted from a draft genome
assembly based on alignment with Helobdella, human, mouse and
rat TRPV protein sequences. Protein sequences are translations of
CDS. Exons missing from the draft annotation are designated with
‘‘n’’ (DNA) or ‘‘X’’ (amino acid). The TRPV3 fragment contains a
well-conserved ankarin domain. All three predicted Hirudo
TRPV’s have best matches with TRPVs in mammals, insects,
and worm.
(TIF)
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